Journey Medical Corporation announced that its FDA-approved treatment for rosacea, Emrosi™, was featured in a segment of “The Balancing Act®” aired on Lifetime TV on June 9, 2025, with a ...

The FDA approved Novavax’s COVID vaccine Nuvaxovid this month, limiting its use to older adults and people over the age of 12 with conditions that put them at risk due to the illness.

What to know about the effort to get rid of artificial food dyes 04:06. The U.S. Food and Drug Administration announced Friday it has approved the use of three color additives from natural sources ...

FDA Approves the AVMAPKI™ FAKZYNJA™ Combination Therapy as the First-Ever Treatment for Adult Patients with KRAS-mutated Recurrent Low-Grade Serous Ovarian Cancer. Share.

The Food and Drug Administration has approved the first at-home test for cervical cancer screening, its maker Teal Health said on Friday, offering an alternative to Pap smears that need to be ...

FDA approves 3 natural dyes for use in food and beverages By . Kristen Rogers. Updated May 11, 2025, 8:20 AM ET. PUBLISHED May 9, 2025, 1:22 PM ET. Video Ad Feedback.

Media Contact: Kendall Tich (650) 467-6800 Advocacy Contact: Meg Harrison (617) 694-7060 Investor Contacts: Loren Kalm (650) 225-3217 Bruno Eschli +41 61 687 5284 ...

The FDA has approved three natural alternatives for food dyes in food and drinks: Galdieria extract blue, butterfly pea flower extract, and calcium phospha Trending Trending ...

At-home screenings are effective alternatives for closing the screening gap. One study found that mailing kits to people overdue for cervical cancer screenings saw a 50% increase compared to ...

Additionally, the effectiveness of single-agent penpulimab-kcqx was determined in Study AK105-202. The study included 125 patients with unresectable or metastatic non-keratinizing NPC who had disease ...

The FDA has approved the popular drug Dupixent (generic name, dupilumab) for adults and kids 12 and up with chronic spontaneous urticaria (CSU), a long-lasting itchy skin condition, when regular ...

The FDA has approved Zevaskyn for the treatment of recessive dystrophic epidermolysis bullosa, the company announced in a press release.With this approval, Zevaskyn (prademagene zamikeracel ...